Web Toolbar by Wibiya
Login | Sign Up AnonymousUser
twiter
New to Comunitee?


or Sign Up with Email

Business

>> CANTOR FITZGERALD Latest News

JUN 06, 2013 - TheStreet

A Must Read - Share

Analysts' Actions: CLVS ENDP THC WRB

NEW YORK (TheStreet) -- CHANGE IN RATINGS Clovis Oncology was upgraded at Piper Jaffray to overweight from neutral. $100 price target. Company offered positive CO-1686 data at ASCO, Piper Jaffray said. Endo Health was downgraded at Cantor Fitzgerald to sell from hold. $30 price target. Expect a prolonged restructuring period, Cantor said. ... Click to view a price quote on CLVS. Click to research the Drugs industry.

Tags: Analysts' Actions: CLVS ENDP THC WRB,  Cantor Fitzgerald Latest News